Newcells Biotech Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 49

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.4M

  • Investors
  • 6

Newcells Biotech General Information

Description

Developer of a biotechnology platform designed to develop in vitro cell-based assays for early drug discovery and development. The company's platform is focused on building models that closely mimic the physiology of the kidney, retina, liver, and lung that improve prediction of safety, pharmacology, and efficacy in humans and commercialized kidney and retina platforms as best in class and development for launch stem cell-based models of the liver and lung, enabling researchers to research and test new drugs and screen potential drug molecules for efficacy and toxicity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Corporate Office
  • The Biosphere, Drayman's Way
  • Newcastle Helix
  • Newcastle Upon Tyne NE4 5BX
  • England, United Kingdom
+44 0191 000 0000

Newcells Biotech Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Newcells Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 14-Feb-2024 $7.4M 000.00 000.00 Completed Generating Revenue
7. Later Stage VC 23-Feb-2021 00.000 000.00 000.00 Completed Generating Revenue
6. Grant 01-Oct-2019 00000 00.000 Completed Generating Revenue
5. Early Stage VC 04-Jul-2018 00.000 00.000 00.000 Completed Generating Revenue
4. Grant 22-Aug-2017 00.000 00000 Completed Generating Revenue
3. Grant 01-Oct-2016 00.000 00000 Completed Generating Revenue
2. Seed Round 02-Sep-2015 $239K $239K 00.000 Completed Generating Revenue
1. Spin-Off 15-Jan-2015 Completed Startup
To view Newcells Biotech’s complete valuation and funding history, request access »

Newcells Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
H2 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
H2 Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
H1 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
H1 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
G Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
G Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
F2 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
F1 Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
E Ordinary 723,141 $0.000127 $3.07 $3.07 1x $3.07 9.78%
D2 Ordinary 105,953 $0.000127 $1.79 $1.79 1x $1.79 1.43%
To view Newcells Biotech’s complete cap table history, request access »

Newcells Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology platform designed to develop in vitro cell-based assays for early drug discovery and develo
Drug Discovery
Newcastle Upon Tyne, United Kingdom
49 As of 2024
000.00
000.00 0000-00-00
0000000000 0 000.00

000000

odo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse ci
0000000000000
Leiden, Netherlands
00 As of 0000
000.00
00000 0000-00-00
0000000000 0 000.00

000000

ididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
0000000000000
Cambridge, United Kingdom
00 As of 0000
000.00
000.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Newcells Biotech Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ncardia Venture Capital-Backed Leiden, Netherlands 00 000.00 0000000000 0 000.00
DefiniGEN Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000000000 000.00
Neurona Therapeutics Venture Capital-Backed South San Francisco, CA 00 00000 00000000000 00000
TiGenix Formerly VC-backed Leuven, Belgium 00 00000 000000&0 00000
BioIVT Private Equity-Backed Hicksville, NY 000 000000000 -
You’re viewing 5 of 25 competitors. Get the full list »

Newcells Biotech Patents

Newcells Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202204371-D0 Fluid flow plate Inactive 28-Mar-2022
GB-202112237-D0 Fluid flow plate Pending 26-Aug-2021 000000000
GB-2610208-A Fluid flow plate Pending 26-Aug-2021 000000000 0
CA-3228082-A1 Fluid flow plate Pending 26-Aug-2021 000000000
GB-201913923-D0 A method for obtaining pluripotent stem cell-derived airway basal-like cells and an airway epithelium model Pending 26-Sep-2019 C12N5/0696
To view Newcells Biotech’s complete patent history, request access »

Newcells Biotech Executive Team (7)

Name Title Board Seat Contact Info
Michael Nicholds Co-Founder, Chief Executive Officer & Board Member
Emanuela Costigliola Ph.D Chief Marketing Officer
Lyle Armstrong Ph.D Co-Founder, Chief Scientific Officer & Board Member
Colin Brown Chief Scientific Officer
Simon Berry Finance Director
You’re viewing 5 of 7 executive team members. Get the full list »

Newcells Biotech Board Members (8)

Name Representing Role Since
Frank Armstrong MD Self Board Member 000 0000
Lyle Armstrong Ph.D Newcells Biotech Co-Founder, Chief Scientific Officer & Board Member 000 0000
Michael Nicholds Newcells Biotech Co-Founder, Chief Executive Officer & Board Member 000 0000
Peter Dines Mercia Asset Management Board Member 000 0000
Terry Pizzie Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Newcells Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Newcells Biotech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Regional Development Fund (Brandenburg) Government Minority 000 0000 000000 0
Northern Venture Trust Venture Capital Minority 000 0000 000000 0
Mercia Asset Management Growth/Expansion Minority 000 0000 000000 0
NVM Private Equity PE/Buyout Minority 000 0000 000000 0
Innovate UK Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Newcells Biotech FAQs

  • When was Newcells Biotech founded?

    Newcells Biotech was founded in 2015.

  • Who is the founder of Newcells Biotech?

    Michael Nicholds, Lyle Armstrong Ph.D, and Majlinda Lako Ph.D are the founders of Newcells Biotech.

  • Who is the CEO of Newcells Biotech?

    Michael Nicholds is the CEO of Newcells Biotech.

  • Where is Newcells Biotech headquartered?

    Newcells Biotech is headquartered in Newcastle Upon Tyne, United Kingdom.

  • What is the size of Newcells Biotech?

    Newcells Biotech has 49 total employees.

  • What industry is Newcells Biotech in?

    Newcells Biotech’s primary industry is Drug Discovery.

  • Is Newcells Biotech a private or public company?

    Newcells Biotech is a Private company.

  • What is the current valuation of Newcells Biotech?

    The current valuation of Newcells Biotech is 000.00.

  • What is Newcells Biotech’s current revenue?

    The current revenue for Newcells Biotech is 000000.

  • How much funding has Newcells Biotech raised over time?

    Newcells Biotech has raised $17.5M.

  • Who are Newcells Biotech’s investors?

    European Regional Development Fund (Brandenburg), Northern Venture Trust, Mercia Asset Management, NVM Private Equity, and Innovate UK are 5 of 6 investors who have invested in Newcells Biotech.

  • Who are Newcells Biotech’s competitors?

    Ncardia, DefiniGEN, Neurona Therapeutics, TiGenix, and BioIVT are some of the 25 competitors of Newcells Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »